S&P 500   4,012.03 (-0.29%)
DOW   32,252.86 (+0.17%)
QQQ   299.92 (-0.67%)
AAPL   146.40 (-0.48%)
MSFT   263.15 (+0.78%)
FB   201.69 (+1.55%)
GOOGL   2,295.50 (-1.10%)
AMZN   2,227.35 (-1.49%)
TSLA   727.97 (-5.41%)
NVDA   174.44 (-1.48%)
BABA   87.30 (-0.78%)
NIO   14.79 (+3.35%)
AMD   95.58 (+0.48%)
CGC   5.76 (-2.70%)
MU   71.15 (-1.07%)
T   20.35 (+2.57%)
GE   75.06 (+0.01%)
F   13.12 (-2.81%)
DIS   105.79 (-1.43%)
AMC   11.69 (-1.02%)
PFE   50.89 (+1.94%)
PYPL   78.07 (-0.96%)
NFLX   187.75 (+0.06%)
S&P 500   4,012.03 (-0.29%)
DOW   32,252.86 (+0.17%)
QQQ   299.92 (-0.67%)
AAPL   146.40 (-0.48%)
MSFT   263.15 (+0.78%)
FB   201.69 (+1.55%)
GOOGL   2,295.50 (-1.10%)
AMZN   2,227.35 (-1.49%)
TSLA   727.97 (-5.41%)
NVDA   174.44 (-1.48%)
BABA   87.30 (-0.78%)
NIO   14.79 (+3.35%)
AMD   95.58 (+0.48%)
CGC   5.76 (-2.70%)
MU   71.15 (-1.07%)
T   20.35 (+2.57%)
GE   75.06 (+0.01%)
F   13.12 (-2.81%)
DIS   105.79 (-1.43%)
AMC   11.69 (-1.02%)
PFE   50.89 (+1.94%)
PYPL   78.07 (-0.96%)
NFLX   187.75 (+0.06%)
S&P 500   4,012.03 (-0.29%)
DOW   32,252.86 (+0.17%)
QQQ   299.92 (-0.67%)
AAPL   146.40 (-0.48%)
MSFT   263.15 (+0.78%)
FB   201.69 (+1.55%)
GOOGL   2,295.50 (-1.10%)
AMZN   2,227.35 (-1.49%)
TSLA   727.97 (-5.41%)
NVDA   174.44 (-1.48%)
BABA   87.30 (-0.78%)
NIO   14.79 (+3.35%)
AMD   95.58 (+0.48%)
CGC   5.76 (-2.70%)
MU   71.15 (-1.07%)
T   20.35 (+2.57%)
GE   75.06 (+0.01%)
F   13.12 (-2.81%)
DIS   105.79 (-1.43%)
AMC   11.69 (-1.02%)
PFE   50.89 (+1.94%)
PYPL   78.07 (-0.96%)
NFLX   187.75 (+0.06%)
S&P 500   4,012.03 (-0.29%)
DOW   32,252.86 (+0.17%)
QQQ   299.92 (-0.67%)
AAPL   146.40 (-0.48%)
MSFT   263.15 (+0.78%)
FB   201.69 (+1.55%)
GOOGL   2,295.50 (-1.10%)
AMZN   2,227.35 (-1.49%)
TSLA   727.97 (-5.41%)
NVDA   174.44 (-1.48%)
BABA   87.30 (-0.78%)
NIO   14.79 (+3.35%)
AMD   95.58 (+0.48%)
CGC   5.76 (-2.70%)
MU   71.15 (-1.07%)
T   20.35 (+2.57%)
GE   75.06 (+0.01%)
F   13.12 (-2.81%)
DIS   105.79 (-1.43%)
AMC   11.69 (-1.02%)
PFE   50.89 (+1.94%)
PYPL   78.07 (-0.96%)
NFLX   187.75 (+0.06%)
NASDAQ:BBBY

Bed Bath & Beyond (BBBY) Stock Forecast, Price & News

$9.40
-0.24 (-2.49%)
(As of 05/16/2022 03:20 PM ET)
Add
Compare
Today's Range
$9.21
$9.77
50-Day Range
$9.22
$27.23
52-Week Range
$8.80
$44.51
Volume
144,008 shs
Average Volume
7.73 million shs
Market Capitalization
$750.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.78
30 days | 90 days | 365 days | Advanced Chart
Receive BBBY News and Ratings via Email

Sign-up to receive the latest news and ratings for Bed Bath & Beyond and its competitors with MarketBeat's FREE daily newsletter.

Bed Bath & Beyond logo

About Bed Bath & Beyond

Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products. As of February 26, 2022, the company had 953 stores, which included 771 Bed Bath & Beyond stores in 50 states, the District of Columbia, Puerto Rico, and Canada; 130 buybuy BABY stores in 37 states and Canada; and 52 stores in 6 states under the names Harmon, Harmon Face Values or Face Values. It also offers products through various Websites and applications comprising bedbathandbeyond.com, bedbathandbeyond.ca, harmondiscount.com, facevalues.com, buybuybaby.com, buybuybaby.ca, and decorist.com. In addition, the company operates Decorist, an online interior design platform that provides personalized home design services. Bed Bath & Beyond Inc. was incorporated in 1971 and is headquartered in Union, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Home furniture, furnishings & equipment stores
Sub-Industry
Homefurnishing Retail
Current Symbol
NASDAQ:BBBY
CUSIP
07589610
Employees
32,000
Year Founded
1971

Sales & Book Value

Annual Sales
$7.87 billion
Cash Flow
$2.84 per share
Book Value
$2.18 per share

Profitability

Net Income
$-559.62 million
Pretax Margin
-6.01%

Debt

Price-To-Earnings

Miscellaneous

Free Float
79,048,000
Market Cap
$750.55 million
Optionable
Optionable

Company Calendar

Last Earnings
4/13/2022
Today
5/16/2022
Next Earnings (Estimated)
6/29/2022
Fiscal Year End
2/28/2023

Social Links


MarketRank

Overall MarketRank

1.39 out of 5 stars

Retail/Wholesale Sector

236th out of 283 stocks

Home Furniture, Furnishings & Equipment Stores Industry

5th out of 5 stocks

Analyst Opinion: 2.8Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Bed Bath & Beyond (NASDAQ:BBBY) Frequently Asked Questions

Is Bed Bath & Beyond a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bed Bath & Beyond in the last year. There are currently 6 sell ratings, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Bed Bath & Beyond stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BBBY, but not buy additional shares or sell existing shares.
View analyst ratings for Bed Bath & Beyond
or view top-rated stocks.

Are investors shorting Bed Bath & Beyond?

Bed Bath & Beyond saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 20,400,000 shares, an increase of 33.6% from the April 15th total of 15,270,000 shares. Based on an average daily trading volume, of 6,890,000 shares, the short-interest ratio is currently 3.0 days. Currently, 29.5% of the shares of the company are short sold.
View Bed Bath & Beyond's Short Interest
.

When is Bed Bath & Beyond's next earnings date?

Bed Bath & Beyond is scheduled to release its next quarterly earnings announcement on Wednesday, June 29th 2022.
View our earnings forecast for Bed Bath & Beyond
.

How were Bed Bath & Beyond's earnings last quarter?

Bed Bath & Beyond Inc. (NASDAQ:BBBY) released its quarterly earnings data on Wednesday, April, 13th. The retailer reported ($0.92) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.94. The retailer earned $2.05 billion during the quarter, compared to the consensus estimate of $2.08 billion. Bed Bath & Beyond had a negative net margin of 7.11% and a negative trailing twelve-month return on equity of 14.09%. The firm's revenue was down 21.7% on a year-over-year basis. During the same period last year, the company earned $0.40 earnings per share.
View Bed Bath & Beyond's earnings history
.

What price target have analysts set for BBBY?

10 brokerages have issued 1 year price targets for Bed Bath & Beyond's shares. Their forecasts range from $7.00 to $26.00. On average, they anticipate Bed Bath & Beyond's share price to reach $13.67 in the next twelve months. This suggests a possible upside of 44.0% from the stock's current price.
View analysts' price targets for Bed Bath & Beyond
or view top-rated stocks among Wall Street analysts.

Who are Bed Bath & Beyond's key executives?
Bed Bath & Beyond's management team includes the following people:
  • Mr. Mark J. Tritton, Pres, CEO & Director (Age 59, Pay $6M)
  • Mr. Gustavo Arnal, Exec. VP & CFO (Age 52, Pay $1.91M) (LinkedIn Profile)
  • Mr. John R. Hartmann, COO, Exec. VP & Pres of buybuy BABY Inc (Age 58, Pay $3.22M) (LinkedIn Profile)
  • Mr. Joseph G. Hartsig, Exec. VP, Chief Merchandising Officer & Pres of Harmon Health & Beauty Stores Inc (Age 58, Pay $1.38M) (LinkedIn Profile)
  • Mr. John S. Barresi, Sr. VP of Fin. & Chief Accounting Officer (Age 49)
  • Mr. Scott Lindblom, Chief Technology Officer
  • Mr. Ronald Curwin, Sr. VP of Investor Relations
  • Ms. Arlene S. Hong Esq., Exec. VP, Chief Legal Officer & Corp. Sec. (Age 53)
  • Mr. Scott Hames, Sr. VP and Chief Marketing & Analytics Officer
  • Ms. Lynda Markoe, Exec. VP and Chief People & Culture Officer (Age 55)
What is Mark Tritton's approval rating as Bed Bath & Beyond's CEO?

191 employees have rated Bed Bath & Beyond CEO Mark Tritton on Glassdoor.com. Mark Tritton has an approval rating of 57% among Bed Bath & Beyond's employees. This puts Mark Tritton in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Bed Bath & Beyond's key competitors?
What other stocks do shareholders of Bed Bath & Beyond own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bed Bath & Beyond investors own include NVIDIA (NVDA), Bank of America (BAC), Micron Technology (MU), Advanced Micro Devices (AMD), Tesla (TSLA), Walt Disney (DIS), Alibaba Group (BABA), Starbucks (SBUX), AT&T (T) and General Electric (GE).

What is Bed Bath & Beyond's stock symbol?

Bed Bath & Beyond trades on the NASDAQ under the ticker symbol "BBBY."

Who are Bed Bath & Beyond's major shareholders?

Bed Bath & Beyond's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (19.53%), Vanguard Group Inc. (12.72%), State Street Corp (4.60%), Dimensional Fund Advisors LP (2.44%), Allianz Asset Management GmbH (2.41%) and Bank of New York Mellon Corp (1.98%). Company insiders that own Bed Bath & Beyond stock include Ann Yerger, Gregg A Melnick, Gustavo Arnal, Harriet Edelman, John E Fleming, John R Hartmann, Joseph G Hartsig, Joshua Schechter and Sue Gove.
View institutional ownership trends for Bed Bath & Beyond
.

Which major investors are selling Bed Bath & Beyond stock?

BBBY stock was sold by a variety of institutional investors in the last quarter, including Brown Advisory Inc., Dimensional Fund Advisors LP, BlackRock Inc., Contrarius Investment Management Ltd, Vanguard Group Inc., Rothschild & Co. Asset Management US Inc., UBS Group AG, and IMC Chicago LLC. Company insiders that have sold Bed Bath & Beyond company stock in the last year include John R Hartmann, and Joseph G Hartsig.
View insider buying and selling activity for Bed Bath & Beyond
or view top insider-selling stocks.

Which major investors are buying Bed Bath & Beyond stock?

BBBY stock was bought by a variety of institutional investors in the last quarter, including Sculptor Capital LP, Royce & Associates LP, Simplex Trading LLC, Invesco Ltd., Bank of Montreal Can, First Trust Advisors LP, Cutler Group LP, and Charles Schwab Investment Management Inc.. Company insiders that have bought Bed Bath & Beyond stock in the last two years include Ann Yerger, Gregg A Melnick, Gustavo Arnal, Harriet Edelman, John E Fleming, John R Hartmann, Joseph G Hartsig, Joshua Schechter, and Sue Gove.
View insider buying and selling activity for Bed Bath & Beyond
or or view top insider-buying stocks.

How do I buy shares of Bed Bath & Beyond?

Shares of BBBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bed Bath & Beyond's stock price today?

One share of BBBY stock can currently be purchased for approximately $9.49.

How much money does Bed Bath & Beyond make?

Bed Bath & Beyond has a market capitalization of $757.74 million and generates $7.87 billion in revenue each year. The retailer earns $-559.62 million in net income (profit) each year or ($5.77) on an earnings per share basis.

How many employees does Bed Bath & Beyond have?

Bed Bath & Beyond employs 32,000 workers across the globe.

Does Bed Bath & Beyond have any subsidiaries?

The following companies are subsidiares of Bed Bath & Beyond: Bed Bath & Beyond Canada L.P., Bed Bath & Beyond of California Limited Liability Company, Buy Buy Baby, Christmas Tree Shops, Cost Plus, Cost Plus Management Services, Decorist, Harbor Linen, Harmon Stores, Liberty Procurement Co. Inc., Of a KIng, One Kings Lane, and PersonalizationMall.com.

When was Bed Bath & Beyond founded?

Bed Bath & Beyond was founded in 1971.

What is Bed Bath & Beyond's official website?

The official website for Bed Bath & Beyond is www.bedbathandbeyond.com.

How can I contact Bed Bath & Beyond?

Bed Bath & Beyond's mailing address is 650 LIBERTY AVENUE, UNION NJ, 07083. The retailer can be reached via phone at (908) 688-0888, via email at [email protected], or via fax at 908-688-6483.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.